Member Info for mulledwine

New IFC Revolving Credit Facility of US$25 million Petra Diamonds announces that its wholly owned subsidiary Finsch Diamond Mine (Pty) Limited ("FDM") has entered into a revolving credit facility agreement (the "IFC Agreement") with IFC (a member of the World Bank Group) with regards to a new revolving credit facility of US$25 million secured on the assets of FDM in respect of the Finsch diamond mine in South Africa ("Finsch") and the Company's interest in FDM. The new facility has been put in place in addition to the ZAR300 million (approximately US$36.9 million) Rand Merchant Bank ("RMB", a division of FirstRand Bank Limited) revolving credit facility that was announced on 30 November 2011. On completion of the IFC Agreement, the ZAR300 million RMB facility will reduce to ZAR200 million (approximately US$24.6 million), so that the lenders together provide circa US$49.6 million in revolving credit facilities to Petra. These IFC (US$25 million) and RMB (ZAR200 million) revolving credit facilities are in addition to the debt facilities of approximately US$76.9 million that were put in place in November 2010 with IFC and RMB (being U$40 million with IFC and approximately US$ 36.9 million (ZAR300 million) with RMB) ("the IFC and RMB 2010 Debt Facilities"). Other than the revolving credit and debt facilities above, Petra also has working capital (overdraft) facilities with RMB/FirstRand Bank Limited of approximately US$20.9 million (ZAR170 million). Petra's total bank debt facilities now amount to approximately US$147.4 million. As at the date of this announcement, Petra has drawn down US$36.5 million of the IFC 2010 Debt Facility and approximately US$32.9 million (ZAR267.1 million) of the RMB 2010 Debt Facility. All other facilities remain undrawn, leaving approximately US$78 million available. Given the lead times between the Group's now larger diamond tenders (post the acquisition of the Finsch mine) and the volatility experienced over the last 12 months of both the Rand and diamond prices, these new revolving credit facilities provide Petra with additional scope and flexibility to execute its capital expenditure programme and bring the Company's stated production and revenue growth opportunities to account. As stated in the Company's recent Interim Management Statement (released 9 May 2012), and separately to this new IFC facility, Petra has commenced discussions with its bankers with regards to the longer term restructure of the Group's debt requirements. It is an opportune time to revisit the Group's debt levels, terms and structure, given that Finsch was not part of the Group when the original debt financing was put in place in 2010 and given the other positive Group developments since this time.

http://www.investegate.co.uk/Article.aspx?id=201207040700078447G

Luis da Silva, Chief Executive Officer of Afferro, commented: "We have been successful in expanding and significantly increasing confidence in the resource base at Nkout, working to unlock value and rapidly advance the project. This fourth resource estimate for Nkout represents a significant boost in Indicated and Inferred material over and above the resource used for the preliminary economic assessment and will extend the projected mine life and enhance the project economics. The work in the first quarter of 2012 focused on de-risking the project and increasing visibility over the full extent of the mineralisation at Nkout. The promotion of 16.7 Mt of potential DSO to the Indicated status at an increased grade of 60.5% iron strengthens our aim of progressing the opportunity to access early cash flows with a small-scale 1-2 Mtpa operation whilst development of larger scale mine takes place. In addition, assay results for reconnaissance drilling of the Nkout zone D8 and the adjoining Ngoa will be provided in a separate update once available. The Company also expects to commission an environmental and social impact assessment later in the year. The focus in the coming months remains the effective use of shareholders' funds to advance technical and economic studies to increase confidence in a project that is already considered to be viable and an attractive option for strategic investment."

Increase of Indicated and Inferred Resources at Nkout Afferro Mining Inc. ("Afferro" or the "Company"), the exploration and development company focused on iron ore in Cameroon, is pleased to announce a fourth National Instrument 43-101 ("NI 43-101") compliant Mineral Resource Estimate ("MRE4") for the Nkout iron ore project ("Nkout"). Highlights: - A 25% increase in the total Indicated resources to 1.19 Billion tonnes ("Bt") at a grade of 32.9% iron - A 27% increase in the total Inferred resources to 1.33 Bt at a grade of 30.3% iron - High grade cap, comprising all material above a mineralised cut-off of 50% Fe, totalling 25.1 Mt, with a grade of 57.7% iron in the Indicated category o Promotion of 16.7 million tonnes ("Mt"), representing 87% of the potential direct shipping ore ("DSO") to the Indicated category with a grade of 60.5% iron o Promotion of 8.4 Mt, representing 49% of the high grade saprolite to the Indicated category, with a grade of 52.0% iron - Metallurgical testwork shows that material above a 50% iron mineralised cut-off is amenable to processing through the potential DSO plant with a mass yield of approximately 75%

http://www.investegate.co.uk/Article.aspx?id=201207040700108722G

CONT IP Group is beneficially interested in 5,612,230 ordinary shares in Revolymer, representing 10.6% of Revolymer's enlarged issued share capital, valued at £5.6 million at the Placing Price. The admission of Revolymer to AIM will result in an unrealised fair value gain to IP Group of £0.2 million at the Placing Price. In addition, IP Venture Fund, a venture capital fund managed by the Group, has a beneficial interest in 2,773,350 ordinary shares, representing 5.2% of Revolymer's enlarged issued share capital. IP Group and IP Venture Fund have committed £2.5 million and £0.35 million respectively to the placing. Revolymer, a spin-out company from the University of Bristol, plans to use the proceeds primarily to expand the distribution of its confectionery gum products in the United States and into Europe, to fund additional regulatory dossiers in connection with its nicotine gum commercialisation, and to fund the development of its consumer specialties products.

IP Group plc - Portfolio company Revolymer announces conditional placing to raise £25m and Admission to AIM IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property based businesses, is pleased to note that portfolio company Revolymer plc ("Revolymer"), best known for its removable chewing gum, has today announced a conditional placing of new ordinary shares with institutional investors to raise gross proceeds of £25 million and that the admission of its entire issued share capital to trading on the AIM market of the London Stock Exchange plc is expected to take place on 10 July 2012. Revolymer (AIM: REVO), the British polymer company developing products for a number of high value fast moving consumer goods (FMCG) markets, has conditionally placed a total of 25,000,000 Placing Shares with institutional investors at a price of 100 pence per Placing Share ("Placing Price") to raise gross proceeds of £25 million. Based on the Placing Price, the market capitalisation of Revolymer on Admission will be approximately £53 million. The Placing is conditional, inter alia, upon Admission.

http://www.investegate.co.uk/Article.aspx?id=201207040711008732G

Current Trading and Outlook The challenging market conditions experienced in our core UK markets are continuing. Although we see considerable opportunities for PathFinderRF and Odyssey sales as Clinical Commissioning Groups become fully established, the NHS is in a transition period in which IT purchasing decisions are being delayed. Although this is restraining our UK business, we anticipate growth from the Company's newly released software hosted services and applications, such as PathFinderRF, Odyssey CareAssess and Odyssey SelfAssess during the second half of the current financial year. The major investment that the Company has continued to make, both in clinical and software development, is targeted at innovative cost-effective hosted, web and mobile delivered software solutions and applications in order to capitalise on new opportunities as they present themselves in the future. While the current level of non-UK sales are still low, we are encouraged by the strength of interest shown from international markets and are optimistic that during the current financial year there will be a shift from the Company's dependence on the UK market towards major international growth markets.

Commenting today, Barry Giddings, Chairman of Avia said: "The financial year to 31 March 2012 was unquestionably a difficult and turbulent year for the Company. We had to manage a difficult financial situation following anticipated sales failing to materialise owing to circumstances beyond the Company's control. As such, we did not make sufficient progress in our strategy of reducing dependency on the UK domestic public healthcare sector and this remains a high priority for the Company. More work is required over the next quarter to stabilise the financial situation of the Company and accordingly we are seeking to raise new capital. Our business agenda is tightly focused on profit. Odyssey remains an exceptionally strong brand and we believe its world-class clinical decision support content alongside our new PathFinderRF software continues to offer significant benefits, including cost savings, to healthcare globally. We are confident that through new partnerships and simplified delivery we will improve the performance of the Company in the coming year. There are a number of prospects and opportunities, which we believe can deliver significant growth. We have been busy developing our software and applications to take advantage of these. As a result we look forward with guarded optimism to the coming year".

4th July 2012 Avia Health Informatics Plc ("Avia" or the "Company") announces its unaudited preliminary results for the year ended 31st March 2012. Summary: Financial · Revenues of £2.3 million (2011: £2.1 million) · Gross margin of 29% (2011: 41%) · Focus on cost control with an annualised reduction of £400k in staff costs · Loss after Tax for the year of £0.63m (2011: £0.65m) · Net current liabilities of £385k include deferred income of £390k · Net cash of £100k at 31 March 2012 · Seeking to raise approximately £1m of new capital in the short term to both provide working capital to secure the business and to underpin the development of the business Operational · PathFinderRF launched for Clinical Commissioning Groups ("CCG") · Successful piloting of Odyssey CareAssess in UK care homes · Odyssey FaceToFace launched in new emergency department and urgent care settings · Odyssey TeleAssess supplied to Swiss health insurance group · Non-exclusive partnership agreement with K3 Healthcare / the Institute of Remote Healthcare · Non-exclusive sales agent appointed in Illinois, USA, to sell Odyssey CareAssess software · Exclusive reseller appointed in Canada to sell the Odyssey software range

http://www.investegate.co.uk/Article.aspx?id=201207040701008471G

Thierry Jadot, CEO Aegis Media France, commented: "We are delighted to welcome the team from W Garden to Aegis Media France. This transaction ensures that iProspect will have the most comprehensive search and performance marketing capability in our market. A strengthened iProspect business will support Aegis Media France in continuing to seize the exciting opportunities the convergent media environment brings and will help us to further consolidate our leading position in the French market."

Acquisition of W Garden strengthens iProspect France Aegis Group plc ("Aegis"), the world's leading, focused media and digital communications group, today announces that it has acquired six subsidiary companies owned by W Garden, Verbal Clint, Allin and others (collectively referred to in this announcement as "W Garden"). In aggregate, the entities had gross assets of €5.0m as at 31 December 2011. W Garden is a leading provider of search and performance marketing solutions, consultancy and software tools, with a particular focus on search engine optimisation. The business has also developed a specialist search capability in the area of social media. Founded in 2007, W Garden's management team has established a strong network of offices across France and has built up a high quality local client base. The acquisition will establish iProspect as one of the leading search and performance marketing specialists in France. This acquisition is in line with the Aegis Group strategy of increasing its digital profile and capability and by acquiring businesses which provide scale and innovation as well as geographic and product in-fill. The integration of W Garden with iProspect France's existing business is expected to be completed early in the third quarter of 2012.

http://www.investegate.co.uk/Article.aspx?id=201207040700098525G

Daniel Stewart initiates buy on William Hill, target price 318p.

Daniel Stewart initiates sell on Metals Exploration, target price 5p.

Daniel Stewart initiates sell on New Britain Palm Oil, target price 657p.

Credit Suisse downgrades Melrose from outperform to neutral, target price cut from 440p to 369p.

Merchant Securities intitiates buy on BTG, target price 490p